TY - JOUR
T1 - Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder
T2 - Analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project
AU - Sajatovic, Martha
AU - Dols, Annemiek
AU - Rej, Soham
AU - Almeida, Osvaldo P.
AU - Beunders, Alexandra J.M.
AU - Blumberg, Hilary P.
AU - Briggs, Farren B.S.
AU - Forester, Brent P.
AU - Patrick, Regan E.
AU - Forlenza, Orestes V.
AU - Gildengers, Ariel
AU - Jimenez, Esther
AU - Vieta, Eduard
AU - Mulsant, Benoit
AU - Schouws, Sigfried
AU - Paans, Nadine
AU - Strejilevich, Sergio
AU - Sutherland, Ashley
AU - Tsai, Shangying
AU - Wilson, Betsy
AU - Eyler, Lisa T.
N1 - Funding Information:
This project was supported by the International Society for Bipolar Disorders (ISBD) Bowden Massey Strategic Research Initiative; US National Institute of Mental Health (R01MH070902, R01MH113230, R01MH084921); Pfizer; Glaxo Smith Kline; Merck; National Health and Medical Research Council of Australia; National Institute for Biomarker Research in Neuropsychiatry, INBION (FAPESP 14/50873-3; 2016/01302-9 and CNPq 465412/2014-9); Associação Beneficente Alzira Denise Hertzog da Silva (ABADHS); Canadian Institutes for Health Research, grant 200017; Ministry of Science and Technology, Taiwan; Spanish Ministry of Science and Innovation (PI15/00283, PI18/00805) integrated into the Plan Nacional de I+D+I and co-financed by the ISCIII-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER); the Instituto de Salud Carlos III; the CIBER of Mental Health (CIBERSAM); the Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement (2017 SGR 1365); the CERCA Programme; and the Departament de Salut de la Generalitat de Catalunya for the PERIS grant SLT006/17/00357. This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of ISBD. The ISBD is a 401c3 non-profit organization whose mission is to foster international collaboration in education and research. For more information, visit www.isbd.org and www.gage-bd.org. The authors thank the following people: Leon Flicker, Graeme J. Hankey, Bu B. Yeap, Jonathan Golledge, Melis Orhan, Nicole Korten, Tokie Kemp, Lejla Colic PhD, Luca Villa PhD, Susan Quatrano, Miranda Skurla, Patrick Monette, Beny Lafer, James Emanuel, Daniel M. Blumberger, and Tarek K. Rajji.
Funding Information:
This project was supported by the International Society for Bipolar Disorders (ISBD) Bowden Massey Strategic Research Initiative; US National Institute of Mental Health (R01MH070902, R01MH113230, R01MH084921); Pfizer; Glaxo Smith Kline; Merck; National Health and Medical Research Council of Australia; National Institute for Biomarker Research in Neuropsychiatry, INBION (FAPESP 14/50873‐3; 2016/01302‐9 and CNPq 465412/2014‐9); Associação Beneficente Alzira Denise Hertzog da Silva (ABADHS); Canadian Institutes for Health Research, grant 200017; Ministry of Science and Technology, Taiwan; Spanish Ministry of Science and Innovation (PI15/00283, PI18/00805) integrated into the Plan Nacional de I+D+I and co‐financed by the ISCIII‐Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER); the Instituto de Salud Carlos III; the CIBER of Mental Health (CIBERSAM); the Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement (2017 SGR 1365); the CERCA Programme; and the Departament de Salut de la Generalitat de Catalunya for the PERIS grant SLT006/17/00357.
Publisher Copyright:
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2022/3
Y1 - 2022/3
N2 - Objective: Literature on older-age bipolar disorder (OABD) is limited. This first-ever analysis of the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE-BD) investigated associations among age, BD symptoms, comorbidity, and functioning. Methods: This analysis used harmonized, baseline, cross-sectional data from 19 international studies (N = 1377). Standardized measures included the Young Mania Rating Scale (YMRS), Hamilton Depression Rating Scale (HAM-D), Montgomery-Asberg Depression Rating Scale (MADRS), and Global Assessment of Functioning (GAF). Results: Mean sample age was 60.8 years (standard deviation [SD] 12.2 years), 55% female, 72% BD I. Mood symptom severity was low: mean total YMRS score of 4.3 (SD 5.4) and moderate-to-severe depression in only 22%. Controlled for sample effects, both manic and depressive symptom severity appeared lower among older individuals (p's < 0.0001). The negative relationship between older age and symptom severity was similar across sexes, but was stronger among those with lower education levels. GAF was mildly impaired (mean =62.0, SD = 13.3) and somatic burden was high (mean =2.42, SD = 1.97). Comorbidity burden was not associated with GAF. However, higher depressive (p < 0.0001) and manic (p < 0.0001) symptoms were associated with lower GAF, most strongly among older individuals. Conclusions: Findings suggest an attenuation of BD symptoms in OABD, despite extensive somatic burden. Depressive symptom severity was strongly associated with worse functioning in older individuals, underscoring the need for effective treatments of BD depression in older people. This international collaboration lays a path for the development of a better understanding of aging in BD.
AB - Objective: Literature on older-age bipolar disorder (OABD) is limited. This first-ever analysis of the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE-BD) investigated associations among age, BD symptoms, comorbidity, and functioning. Methods: This analysis used harmonized, baseline, cross-sectional data from 19 international studies (N = 1377). Standardized measures included the Young Mania Rating Scale (YMRS), Hamilton Depression Rating Scale (HAM-D), Montgomery-Asberg Depression Rating Scale (MADRS), and Global Assessment of Functioning (GAF). Results: Mean sample age was 60.8 years (standard deviation [SD] 12.2 years), 55% female, 72% BD I. Mood symptom severity was low: mean total YMRS score of 4.3 (SD 5.4) and moderate-to-severe depression in only 22%. Controlled for sample effects, both manic and depressive symptom severity appeared lower among older individuals (p's < 0.0001). The negative relationship between older age and symptom severity was similar across sexes, but was stronger among those with lower education levels. GAF was mildly impaired (mean =62.0, SD = 13.3) and somatic burden was high (mean =2.42, SD = 1.97). Comorbidity burden was not associated with GAF. However, higher depressive (p < 0.0001) and manic (p < 0.0001) symptoms were associated with lower GAF, most strongly among older individuals. Conclusions: Findings suggest an attenuation of BD symptoms in OABD, despite extensive somatic burden. Depressive symptom severity was strongly associated with worse functioning in older individuals, underscoring the need for effective treatments of BD depression in older people. This international collaboration lays a path for the development of a better understanding of aging in BD.
KW - aging
KW - bipolar disorder
KW - depression
KW - functioning
KW - mania
KW - medical burden
UR - http://www.scopus.com/inward/record.url?scp=85112225911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112225911&partnerID=8YFLogxK
U2 - 10.1111/bdi.13119
DO - 10.1111/bdi.13119
M3 - Article
C2 - 34314549
AN - SCOPUS:85112225911
SN - 1398-5647
VL - 24
SP - 195
EP - 206
JO - Bipolar Disorders
JF - Bipolar Disorders
IS - 2
ER -